Recently, we and others have shown that peroxisome proliferator-activated receptor (PPAR) and PPAR gamma coactivator 1-α (PGC-1α) activating drugs improve mitochondrial mass/function and, in turn, ameliorate insulin resistance and diabetes [34,35,36]. The gene discussed is PPARGC1A; the disease is diabetes mellitus.